Sign in:
Email
 Password  save:
  
 Company Reports 
 

   
My Recent Searches
  Help
 
   
 
 
   Get Roster for :  
Inhibikase Therapeutics, Inc. (IKT)  
$0.61 0.00 (0.00%) as of 4:30 Thu 6/29


Download
   
  Company Roster

Total Insiders  : 9  
Total Direct Shares :
20,395,780
Total Indirect Shares :
1,892,732
 
% Held by Insiders:
27.44%
 
4 other people own 
 $158,991 Vincent Aurentz
 $467,196 Cabell Christopher
 $619,056 Werner Milton H.
 $3,254,614 Sands Frank M.
 $7,941,569  
 
Filer's Name Relation Direct Date   Direct Shares Indirect Date Indirect Shares
   Sands Frank M. 10% Owner 2025-11-21 13,018,965 0
   Mcintyre David 2025-04-14 10,285 0
   Munshi Amit 2025-02-21 57,265 2025-02-21 365,000
   Vincent Aurentz 2025-02-21 765,895 0
   Cabell Christopher 2025-02-21 1,014,846 0
   Bellini Roberto 2024-10-21 0 2024-10-21 1,460,000
   Kush Arvind 2024-10-21 145,000 2024-10-21 0
   Werner Milton H. President and CEO, Director, 10% Owner 2022-08-16 5,335,433 2021-11-17 23,589
   Frattaroli Joseph Chief Financial Officer 2022-05-19 48,091 2020-12-28 44,143
9 Records found